Literature DB >> 30099047

Breast cancer screening programme participation and socioeconomic deprivation in France.

Thérèse Deborde1, Edouard Chatignoux1, Cécile Quintin1, Nathalie Beltzer1, Françoise F Hamers1, Agnès Rogel2.   

Abstract

The objective was to quantify the relationship between deprivation and national breast cancer screening programme (NBCSP) participation at an ecological level in mainland France. Data from 4,805,390 women-living in 36,209 municipalities within 95 departments-participating in the 2013-2014 NBCSP were analysed using the French Deprivation Index (FDep). FDep population quintiles by municipality were computed to describe NBCSP participation according to deprivation. To better examine the relationship between continuous value of deprivation index and participation rates at the municipality level, we built a generalized linear mixed model. Geographical variations in participation rates were marked. The national standardized participation rate was higher in the intermediate quintiles (55%), 45% for the least deprived one and 52% for the most deprived one. Using our model, we also obtained an inverted U-curve for the relationship between NBCSP participation and municipality deprivation: participation was lower for both the least and most deprived municipalities. This relationship was also observed for each of the two subpopulations-urban municipalities and rural ones-considered separately. Introducing the FDep in the model reduced slightly the unexplained variations in participation rates between departments and between municipalities (with a proportional change in variance of 14% and 12% respectively). We highlight major disparities in departmental participation rates and FDep/participation profiles. However, deprivation appears to have only little influence on geographical variation in participation rates. There is a need to further understand the factors affecting geographical variation in participation rates, in particular the use of opportunistic screening.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer screening programmes; Deprivation index; Mammography screening; Prevention; Screening programme participation; Socioeconomic inequalities

Mesh:

Year:  2018        PMID: 30099047     DOI: 10.1016/j.ypmed.2018.08.006

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  5 in total

1.  The breast cancer paradox: A systematic review of the association between area-level deprivation and breast cancer screening uptake in Europe.

Authors:  Dinah Smith; Katie Thomson; Clare Bambra; Adam Todd
Journal:  Cancer Epidemiol       Date:  2019-03-28       Impact factor: 2.984

2.  Mapping Variation in Breast Cancer Screening: Where to Intervene?

Authors:  Cindy M Padilla; François Painblanc; Patricia Soler-Michel; Veronica M Vieira
Journal:  Int J Environ Res Public Health       Date:  2019-06-27       Impact factor: 3.390

3.  Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis.

Authors:  Rebecca Mottram; Wendy Lynn Knerr; Daniel Gallacher; Hannah Fraser; Lena Al-Khudairy; Abimbola Ayorinde; Sian Williamson; Chidozie Nduka; Olalekan A Uthman; Samantha Johnson; Alexander Tsertsvadze; Christopher Stinton; Sian Taylor-Phillips; Aileen Clarke
Journal:  BMJ Open       Date:  2021-11-30       Impact factor: 2.692

4.  Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France.

Authors:  Cyrille Delpierre; Pascale Grosclaude; Lisa Ouanhnon; Marie-Eve Rougé Bugat; Sebastien Lamy; Vladimir Druel
Journal:  BMJ Open       Date:  2022-02-22       Impact factor: 2.692

5.  Evaluation of a mobile mammography unit: concepts and randomized cluster trial protocol of a population health intervention research to reduce breast cancer screening inequalities.

Authors:  Elodie Guillaume; Quentin Rollet; Ludivine Launay; Séverine Beuriot; Olivier Dejardin; Annick Notari; Elodie Crevel; Ahmed Benhammouda; Laurent Verzaux; Marie-Christine Quertier; Guy Launoy
Journal:  Trials       Date:  2022-07-08       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.